Harnessing Tumor Mutations for Truly Individualized Cancer Vaccines

Mainz, February 5, 2019 – TRON is thrilled to announce a review published in Annual Review of Medicine authored by Ugur Sahin.

In this overview article targeting the medical community, Prof. Sahin defines the cancer mutanome and why this is a valuable source of potential vaccines targets in oncology. The review goes on to describe the preclinical and clinical state of individualized cancer vaccine development and the challenges ahead.
You can read more on this exciting topic here.

DOI: 10.1146/annurev-med-042617-101816